跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HYATE:C - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
HYATE:C
Authorized
STANDARD
HYATE:C
IPSEN BIOPHARM LIMITED
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
3e41769199673484
Company
IPSEN BIOPHARM LIMITED
Type
Standard
Approval Details
Approval Id
3e41769199673484
Drug Approval Canada Name
HYATE:C
Product Name
HYATE:C
Status
Cancelled Post Market
Status Date
2007-07-31
Original Market Date
1996-12-31
Din
02156075
Drug Class
Human
Dosage Form
Powder For Solution
Route Of Administration
Intravenous
Schedule
Schedule D
Ahfs
20:28.16
Atc Original
B02BD02 COAGULATION FACTOR VIII
Atc Name
b 02 bd 02
Aig Number
0127425001
Company Name
IPSEN BIOPHARM LIMITED
Company Address
UNIT 9, Ash Road, Wrexham Industrial Estate, Wrexham, Wales, United Kingdom, LL13 9UF
Company Detail Path
/organization/ipsen-biopharm-limited
Company Information
Pharmaceutical Company Name
IPSEN BIOPHARM LIMITED
Country Name
United Kingdom
City Name
wrexham,country_gb
Address
ASH ROAD, WREXHAM INDUSTRIAL ESTATE
Active Ingredients
PORCINE FACTOR VIII-C
700 UNIT / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
3e41769199673484
Type
Standard
Back to Health Canada Approvals